Stereoselective synthesis of GABOB, carnitine and statine phosphonates analogues

Tetrahedron Asymmetry

Volumn 21, Issue 2, 2010, Pages 129-147

  Ordóñez, Mario ^a   Labastida Galván, Victoria ^a   Lagunas Rivera, Selene ^a  

^a CENTRO DE INVESTIGACIONES QUÍMICAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXY 3 [[ 1 ( 3,4,5 TRIMETHOXYPHENYL)ETHYL]AMINO]CYCLOHEXYLMETHYLPHOSPHINIC ACID; 2,3 DIHYDROXYPROPYLPHOSPHONIC ACID; 2,3 EPOXYPROPYLPHOSPHONIC ACID; 3 (N BENZYL N HYDROXYAMINO) 2 HYDROPROPYLPHOSPHONIC ACID; 3 (N BENZYLOXYAMINO) 2 HYDROXYPROPYLPHOSPHONIC ACID; 3 [1 [3 [(CYCLOHEXYLMETHYL)HYDROXYPHOSPHINYL] 2 HYDROXYPROPYLAMINO]ETHYL]BENZOIC ACID; 3 BROMO 2 OXOPROPYLPHOSPHONIC ACID; 3 CHLORO 2 HYDROXYPROPYLPHOSPHONIC ACID; 3 CHLORO 2 OXOPROPYLPHOSPHONIC ACID; 4 AMINO 3 HYDROXYBUTYRIC ACID; [ 1 ( 3,4 DICHLOROPHENYL)ETHYL]AMINO 2 HYDROXYPROPYLBENZYLPHOSPHINIC ACID; BETA KETOPHOSPHONIC ACID; CARNITINE; CARNITINE DERIVATIVE; CGP 44532; CGP 44533; CGP 51176; CGP 55679; CGP 55845 A; CHLOROHYDRIN DERIVATIVE; EPICHLOROHYDRIN; ETHYLENE OXIDE; FR 33699; GAMMA AMINO BETA HYDROXYPROPYLPHOSPHINIC ACID; GAMMA AMINO BETA(HYDROXYPROPYL)CYCLOHEXYLMETHYLPHOSPHINIC ACID; GAMMA AMINO BETA(HYDROXYPROPYL)METHYLPHOSPHINIC ACID; GAMMA AMINOPHOSPHONIC ACID; N BENZYL BIS[ 2 (O,O DIETHYLPHOSPHORYLMETHYL)ETHANOL]AMINE; PHOSPHOCARNITINE; PHOSPHONIC ACID DERIVATIVE; PHOSPHORAMIDIC ACID DERIVATIVE; PHOSPHOSTATINE; STATINE DERIVATIVE; STATINE PHOSPHONIC ACID DERIVATIVE; TARTARIC ACID DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALDOL REACTION; ASYMMETRIC SYNTHESIS; DIASTEREOISOMER; DRUG MECHANISM; DRUG SYNTHESIS; ENANTIOMER; ENZYME ACTIVITY; HYDROGENATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RING OPENING; STEREOCHEMISTRY; SUBSTITUTION REACTION;

EID: 77949542019     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2009.12.022     Document Type: Review

References (219)

1. For an excellent review on the stereoselective synthesis of γ-amino acids, see:. Ordóñez M., and Cativiela C. Tetrahedron: Asymmetry 18 (2007) 3-99
2. Zhu J., and Ma D. Angew. Chem., Int. Ed. 42 (2003) 5348-5351
3. Qureshi A., Colin P.L., and Faulkner D. Tetrahedron 56 (2000) 3679-3685
4. Sasaki S., Hamada Y., and Shiori T. Synlett (1999) 453-455
5. Schmidt E.W., and Faulkner D.J. Tetrahedron 54 (1998) 3043-3056
6. Bewley C.A., Debitus C., and Faulkner D.J. J. Am. Chem. Soc. 116 (1994) 7631-7636
7. Otzuka M., Obata K., Miyata Y., and Tanaka Y. J. Neurochem. 18 (1971) 287-295
8. Buscanino G.A., and Ferrari E. Acta Neurol. 16 (1961) 748-771
9. Ong J., Bexis S., Marino V., Parker D.A.S., Kerr D.I.B., and Froestl W. Eur. J. Pharmcol. 412 (2001) 27-37
10. Falch E., Hedegaard A., Nielsen B., Jensen B.R., Hjeds H., and Krogsgaard-Larsen P. J. Neurochem. 47 (1986) 898-903
11. Johnston G.A.R., Allan R.D., Andrews P.R., Kennedy S.M.E., and Twitchin B. Advance in Pharmacology and Therapeutics (1979), Pergamon, Oxford 11
12. Kurano, M.; Miyarnoto, S.; Shigeoka, S.; Mori, A. Japan Kokai, 1976, 76.100.026; Chem. Abstr. 1977, 86, 89207n.
13. Brehm L., Jacobsen P., Johansen J.S., and Krogsgaardt-Larsen P. J. Chem. Soc., Perkin Trans. I (1983) 1459-1464
14. De Simone C., and Famularo G. Carnitine Today (1997), Springer, Heidelberg
15. Ferrari R., Di Mauro S., and Sherwood G. L-Carnitine and its Role in Medicine: From Function to Therapy (1992), Academic Press, San Diego
16. Fritz I.B. In: Karter A.L. (Ed). Current Concepts in Carnitine Research (1992), CRC 107-119
17. Umezawa H., Aoyagi T., Marishima H., Matsuzaki M., Hamada M., and Takeuchi T. J. Antibiot. 23 (1970) 259-262
18. Pesenti C., Arnone A., Bellosta S., Bravo P., Canavesi M., Corradi E., Frigerio M., Meille S.V., Monetti M., Panzeri W., Viani F., Venturini R., and Zanda M. Tetrahedron 57 (2001) 6511-6522
19. Pesenti C., Arnone A., Aubertin A.M., Bravo P., Frigerio M., Panzeri W., Schmidt S., Viani F., and Zanda M. Tetrahedron Lett. 41 (2000) 7239-7243
20. Hom R.K., Fang L.Y., Mamo S., Tung J.S., Guinn A.C., Walker D.E., Davies D.L., Gailunas A.F., Thorsett E.D., Sinha S., Knops J.E., Jewett N.E., Anderson J.P., and John V. J. Med. Chem. 46 (2003) 1799-1802
21. Moore M.L., Bryan W.M., Fakhury S.A., Magaard V.W., Huffan W.F., Dayton B.D., Meek T.K., Hyland L.J., Dreyer G.B., Metcalf B.W., Gorniak J.G., and Debouck C. Biochem. Biophys. Res. Commun. 159 (1989) 420-425
22. Roger J., Lohr N.S., Ulm E.H., Poe M., Blaine E.H., Fanelli G.M., Lin T.-H., Payne L.S., Schorm T.W., LaMont B.I., Vassil T.C., Stabilito I.I., Veber D., Rich D.H., and Bopari A.S. Nature (London) 303 (1983) 81-84
23. Guégan R., Diaz J., Cazaubon C., Beaumont M., Carlet C., Clément J., Demarne H., Mellet M., Richaud J.-P., Segondy D., Vedel M., Cagnol J.-P., Roncucci R., Castro B., Corvol P., Evin G., and Roques B.P. J. Med. Chem. 29 (1986) 1152-1159 and references cited therein
24. Rich D.H. J. Med. Chem. 28 (1985) 263-273
25. For excellent review on the stereoselective synthesis of α-aminophosphonic acids and derivatives, see:. Ordóñez M., Rojas-Cabrera H., and Cativiela C. Tetrahedron 65 (2009) 3-99
26. For the synthesis and biological properties of α-aminophosphonic acids and derivatives, see:. In: Kukhar V.P., and Hudson H.R. (Eds). Aminophosphonic and Aminophosphinic Acids (2000), John Wiley & Sons, New York
27. Kafarsky P., and Lejczak B. Phosphorous Sulfur Silicon 63 (1991) 193-215
28. McLeod D.A., Brinkworth R.I., Ashley J.A., Janda K.D., and Wirsching P. Bioorg. Med. Chem. Lett. 1 (1991) 653-658
29. For the synthesis and biological properties of hydroxyphosphonates, see:. Kolodiazhnyi O.I. Russ. Chem. Rev. 75 (2006) 227-253
30. Kolodiazhnyi O.I. Tetrahedron: Asymmetry 16 (2005) 3295-3340
31. Dingwall J.G. Phosphorus Sulfur 18 (1983) 353-356
32. Hashimoto M., Hemmi K., Takeno H., and Kamiya T. Tetrahedron Lett. 21 (1980) 99-102
33. Kamiya T., Hemmi K., Takeno H., and Hashimoto M. Tetrahedron Lett. 21 (1980) 95-98
34. Kojo H., Shigi Y., and Nishida M. J. Antibiot. 33 (1980) 44-48
35. Mine Y., Kamimura T., Nonoyama S., and Nishida M. J. Antibiot. 33 (1980) 36-43
36. Okuhara M., Kuroda Y., Goto T., Okamoto M., Terano H., Kohsaka M., Aoki H., and Imanaka H. J. Antibiot. 33 (1980) 29-35
37. Okuhara M., Kuroda Y., Goto T., Okamoto M., Terano H., Kohsaka M., Aoki H., and Imanaka H. J. Antibiot. 33 (1980) 24-28
38. Iguchi E., Okuhara M., Kohsaka M., Aoki H., and Imanka H. J. Antibiot. 33 (1980) 18-23
39. Seto H., and Kusuyama T. Nat. Prod. Rep. 16 (1999) 589-596
40. Wiesner J., and Jomaa H. Curr. Drug Targets 8 (2007) 3-13
41. Schweitzer B.A., Loida P.J., CaJacob C.A., Chott R.C., Collantes E.M., Hegde S.G., Mosier P.D., and Profeta S. Bioorg. Med. Chem. Lett. 12 (2002) 1743-1746
42. Mori I., Iwasaki G., Kimura Y., Matsunaga S.-I., Ogawa A., Nakano T., Buser H.-P., Hatano M., Tada S., and Hayakawa K. J. Am. Chem. Soc. 117 (1995) 4411-4412
43. For histidine biosynthesis, see:. Martin R.G., Berbereich M.A., Ames B.N., Davis W.W., Goldberger R.F., and Yourno J.D. In: Tabor H., and Tabor C.W. (Eds). Methods in Enzymology Vol. 17B (1971), Academic, New York 3-44
44. Miflin B.J. In: Miflin B.J. (Ed). The Biochemistry of Plants Vol. 5 (1980), Academic, New York 533-539
45. For the application of analogues of phosphocarnitine as potential antidiabetic agents, see:. Giannessi F., Chiodi P., Marzi M., Minetti P., Pessotto P., De Angelis F., Tassoni E., Conti R., Giorgi F., Mabilia M., Dell'Uomo N., Muck S., Tinti M.O., Carminati P., and Arduini A. J. Med. Chem. 44 (2001) 2383-2386
46. Alstermark C., Amin K., Dinn S.R., Elebring T., Fjellström O., Fitzpatrick K., Geiss W.B., Gottfries J., Guzzo P.R., Harding J.P., Holmén A., Kothare M., Lehmann A., Mattsson J.P., Nilsson K., Sundén G., Swanson M., von Unge S., Woo A.M., Wyle M.J., and Zheng X. J. Med. Chem. 51 (2008) 4315-4320
47. Hinton T., Chebib M., and Johnston G.A.R. Bioorg. Med. Chem. Lett. 18 (2008) 402-404
48. Froestl W., Mickel S.J., Hall R.G., von Sprecher G., Strub D., Baumann P.A., Brugger F., Gentsch C., Jaekel J., Olpe H.-R., Rihs G., Vassout A., Waldmeier P.C., and Bittiger H. J. Med. Chem. 38 (1995) 3297-3312
49. Bowery N.G., Bettler B., Froestl W., Gallagher J.P., Marshall F., Raiteri M., Bonner T.I., and Enna S.J. Pharmacol. Rev. 54 (2002) 247-264
50. Pozza M.F., Manuel N.A., Steinmann M., Froestl W., and Davies C.H. Br. J. Pharmacol. 127 (1999) 211-219
51. Chebib M., Vandenber R.J., Froestl W., and Johnston G.A.R. Eur. J. Pharmacol. 329 (1997) 223-229
52. Froestl W., Mickel S.J., von Sprecher G., Diel P.J., Hall R.G., Maier L., Strub D., Melillo V., Baumann P.A., Bernasconi R., Gentsch C., Hauser K., Jaekel J., Karlsson G., Klebs K., Maître L., Marescaux C., Pozza M.F., Schmutz M., Steinmann M.W., van Riezen H., Vassout A., Mondadori C., Olpe H.-R., Waldmeier P.C., and Bittiger H. J. Med. Chem. 38 (1995) 3313-3331
53. Tadeusiak E., Krawiecka B., and Michalski J. Tetrahedron Lett. 40 (1999) 1791-1792
54. Froestl W., Mickel S.J., Hall R.G., von Sprecher G., Strub D., Baumman P.A., Brugger F., Gentsch C., Jaeckel J., Olpe H.-R., Rihs G., Vassout A., Waldmeier P.C., and Bittiger H. J. Med. Chem. 38 (1995) 3297-3312
55. Wróblewski A.E., and Hałajewska-Wosik A. Tetrahedron: Asymmetry 11 (2000) 2053-2055
56. For the preparation of racemic 32 and derivatives, see:. Verbruggen C., De Craecker S., Rajan P., Jiao X.-Y., Borloo M., Smith K., Fairlamb A.H., and Haemers A. Bioorg. Med. Chem. Lett. 6 (1996) 253-258
57. Bakalarz A., Heliński J., Krawiecka B., Michalski J., and Potrzebowski M.J. Tetrahedron 55 (1999) 12211-12226
58. Heliński J., Skrzypczński Z., and Michalski J. Tetrahedron 50 (1995) 9201-9204
59. Wróblewski A.E., and Balcerzak K.B. Tetrahedron 54 (1998) 6833-6840
60. Wróblewski A.E., and Balcerzak K.B. Tetrahedron: Asymmetry 13 (2002) 845-850
61. Wróblewski A.E., and Ba{ogonek}k-Sypień I.I. Tetrahedron: Asymmetry 18 (2007) 2218-2226
62. Similar results were obtained using benzhydrylamine.
63. Wróblewski A.E., and Hałajewska-Wosik A. Tetrahedron: Asymmetry 14 (2003) 3359-3363
64. Wróblewski A.E., and Hałajewska-Wosik A. Tetrahedron: Asymmetry 15 (2004) 3201-3205
65. Wróblewski A.E., and Hałajewska-Wosik A. Synthesis (2006) 989-994
66. Wróblewski A.E., and Hałajewska-Wosik A. Eur. J. Org. Chem. (2002) 2758-2763
67. Wróblewski A.E., and Hałajewska-Wosik A. Tetrahedron: Asymmetry 15 (2004) 2075-2077
68. Boer E., and Basu H. Can. J. Biochem. 47 (1969) 955-960
69. Hemmi K., Takeno H., Hashimoto M., and Kamiya T. Chem. Pharm. Bull. 29 (1981) 646-650
70. Yamagishi T., Fujii K., Shibuya S., and Yokomatsu T. Tetrahedron 62 (2006) 54-65
71. Yamagishi T., Fujii K., Shibuya S., and Yokomatsu T. Synlett (2004) 2505-2508
72. Ordóñez M., González-Morales A., and Salazar-Fernández H. Tetrahedron: Asymmetry 15 (2004) 2719-2725
73. Juaristi E., Murer P., and Seebach D. Synthesis (1993) 1243-1246
74. The compounds (S,S)-61 and (R,R)-61 were obtained also in 25 and 15% yield, respectively see:. Yamashita A., Norton E.B., Williamson R.T., Ho D.M., Sinishtaj S., and Mansour T.S. Org. Lett. 5 (2003) 3305-3308
75. Reduction of (S)- and (R)-γ-(N-benzyl-N-α-methylbenzyl)amino-β-oxopropylphosphonates afforded the corresponding β-hydroxyphosphonates in good yield but with only low diastereoselectivity.
76. Nesterov V.V., and Kolodyazhnyi O.I. Russ. J. Gral. Chem. 76 (2006) 1022-1030
77. Nesterov V.V., and Kolodyazhnyi O.I. Russ. J. Gral. Chem. 76 (2006) 1510-1511
78. Nesterov V.V., and Kolodiazhnyi O.I. Tetrahedron: Asymmetry 17 (2006) 1023-1026
79. Nesterov V.V., and Kolodiazhnyi O.I. Tetrahedron 63 (2007) 6720-6731
80. Nesterov V.V., and Kolodyazhnyi O.I. Russ. J. Gral. Chem. 76 (2006) 1677-1678
81. Nesterov V.V., and Kolodiazhnyi O.I. Synlett (2007) 2400-2404
82. Wolfson A., Dlugy C., Tavor D., Blumenfeld J., and Shotland Y. Tetrahedron: Asymmetry 17 (2006) 2043-2045
83. Rodrigues J.A.R., Moran P.J.S., and Conceição G.J.A. Food Technol. Biotechnol. 42 (2004) 295-303
84. Nakamura K., Yamanaka R., Matsuda T., and Harada T. Tetrahedron: Asymmetry 14 (2003) 2659-2681
85. Ema T., Sugiyama Y., Fukumoto M., Moriya H., Cui J.-N., Sakai T., and Utaka M. J. Org. Chem. 63 (1998) 4996-5000
86. Symancyk-Duda E., Lejczak B., Kafarski P., Grimaud J., and Fischer P. Tetrahedron 51 (1995) 11809-11814
87. Csuk R., and Glänzer B.I. Chem. Rev. 91 (1991) 49-97
88. Yuan C.-y., Wang K., and Li Z.-y. Heteroat. Chem. 12 (2001) 551-556
89. Yuan C.-y., Wang K., Li J., and Li Z.-y. Phosphorous, Sulfur Silicon 177 (2002) 2391-2397
90. Griffin C.E., and Kundu S.K. J. Org. Chem. 34 (1969) 1532-1539
91. Dale J.A., and Mosher H.S. J. Am. Chem. Soc. 95 (1973) 512-519
92. Leiro V., Seco J.M., Quiñoá E., and Riguera R. Org. Lett. 10 (2008) 2733-2736
93. Freire F., Calderón F., Seco J.M., Fernández-Mayorales A., Quiñoá E., and Riguera R. J. Org. Chem. 72 (2007) 2297-2301
94. García R., Seco J.M., Vázquez S.A., Quiñoá E., and Riguera R. J. Org. Chem. 71 (2006) 1110-1130
95. Kang C.-Q., Guo H.-Q., Qiu X.-P., Bai X.-L., Yao H.-B., and Gao L.-X. Magn. Reson. Chem. 44 (2006) 1-105
96. Freire F., Seco J.M., Quiñoá E., and Riguera R. Org. Lett. 7 (2005) 4855-4858
97. Seco J.M., Quiñoá E., and Riguera R. Chem. Rev. 104 (2004) 17-118 and references cited therein
98. Ordóñez M., González-Morales A., Ruíz C., De la Cruz-Cordero R., and Fernández-Zertuche M. Tetrahedron: Asymmetry 14 (2003) 1775-1779
99. González-Morales A., Fernández-Zertuche M., and Ordóñez M. Rev. Soc. Quím. Méx. 48 (2004) 239-245
100. For the resolution and assignment of the absolute configuration of β-hydroxyphosphonates using MPA, see:. Rojas-Cabrera H., Fernández-Zertuche M., García-Barradas O., Muñoz-Muñiz O., and Ordóñez M. Tetrahedron: Asymmetry 18 (2007) 142-148
101. González-Morales A., Díaz-Coutiño D., Fernández-Zertuche M., García-Barradas O., and Ordóñez M. Tetrahedron: Asymmetry 15 (2004) 457-463
102. For the assignment of the absolute configuration of hydroxy- and aminophosphonates by NMR spectroscopy, see:. Błażewska K.M., and Gajda T. Tetrahedron: Asymmetry 20 (2009) 1337-1361
103. Mikołajczyk M., Łuczak J., and Kiełbasinski P. J. Org. Chem. 67 (2002) 7872-7875
104. For the biocatalytic synthesis of chiral non-racemic β-hydroxyalkanephosphonates, see:. Zurawiński R., Nakamura K., Drabowicz J., Kiełbasinski P., and Mikołajczyk M. Tetrahedron: Asymmetry 12 (2001) 3139-3145
105. Wang K., Zhang Y., and Yuan C. Org. Biomol. Chem. 1 (2003) 3564-3569
106. For catalytic asymmetric synthesis of α- and β-aminophosphonic acid derivatives, see:. Ma J.-A. Chem. Soc. Rev. 35 (2006) 630-636
107. For related references, see:. Burk M.J., Stammers T.A., and Straub J.A. Org. Lett. 1 (1999) 387-390
108. Holz J., Quirmbach M., Schmidt U., Heller D., Stürmer R., and Börner A. J. Org. Chem. 63 (1998) 8031-8034
109. Schmidt U., Krause H.W., Oehme G., Michalik M., and Fischer C. Chirality 10 (1998) 564-572
110. Grassert I., Schmidt U., Ziegler S., Fischer C., and Oehme G. Tetrahedron: Asymmetry 9 (1998) 4193-4202
111. Schmidt U., Oehme G., and Krause H. Synth. Commun. 26 (1996) 777-781
112. Schöllkopf U., Hoppe I., and Thiele A. Liebigs Ann. Chem. (1985) 555-559
113. Gridnev I.D., Yasutake M., Imamoto T., and Beletskaya I.P. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 5385-5390
114. Wang D.-Y., Huang J.-D., Hu X.-P., Deng J., Yu S.-B., Duan Z.-C., and Zheng Z. J. Org. Chem. 73 (2008) 2011-2014
115. Holz J., Stürmer R., Schmidt U., Drexler H.-J., Heller D., Krimmer H.-P., and Börner A. Eur. J. Org. Chem. (2001) 4615-4624
116. Vargas S., Suárez A., Álvarez E., and Pizzano A. Chem. Eur. J. 14 (2008) 9856-9859
117. Nieschalk J., Batsanov A.S., O'Hagan D., and Howard J.A.K. Tetrahedron 52 (1996) 165-176
118. Burke Jr. T.R., Smyth M.S., Nomizu M., Otaka A., and Roller P.P. J. Org. Chem. 58 (1993) 1336-1340
119. Dellaria Jr. J.F., Maki R.G., Stein H.H., Cohen J., Whittern D., Marsh K., Hoffman D.J., Plattner J.J., and Perun T.J. J. Med. Chem. 33 (1990) 534-542
120. Chakravarty P.K., Greenlee W.J., Parsons W.H., Patchett A.A., Combs P., Roth A., Busch R.D., and Mellin T.N. J. Med. Chem. 32 (1989) 1886-1890
121. Cui P., McCalmont W.F., Tomsig J.L., Lynch K.R., and Macdonald T.L. Bioorg. Med. Chem. 16 (2008) 2212-2225
122. Hale J.J., Neway W., Mills S.G., Hajdu R., Keohane C.A., Rosenbach M., Milligan J., Shei G.-J., Chrebet G., Bergstrom J., Card D., Koo G.C., Koprak S.L., Jackson J.J., Rosen H., and Mandala S. Bioorg. Med. Chem. Lett. 14 (2004) 3351-3355
123. Chang R., Vo T.-T., and Finney N.S. Carbohydr. Res. 341 (2006) 1998-2004
124. Torres-Sánchez M.I., Zaccaria C., Buzzi B., Miglio G., Lombardi G., Polito L., Russo G., and Lay L. Chem. Eur. J. 13 (2007) 6623-6635
125. Ciardi C., Romerosa A., Serrano-Ruiz M., Gonsalvi L., Peruzzini M., and Reginato G. J. Org. Chem. 72 (2007) 7787-7789
126. Evans E.B., Rittle K.E., Homnick C.F., Springer J.P., Hirshfield J., and Veber D.F. J. Org. Chem. 50 (1985) 4615-4625
127. Reetz M.T., and Lee W.K. Org. Lett. 3 (2001) 3119-3120
128. Reetz M.T. Chem. Rev. 99 (1999) 1121-1162 and references cited therein
129. Reetz M.T., Drenes M.W., Lennick K., Schmitz A., and Holdrün X. Tetrahedron: Asymmetry 1 (1990) 375-378
130. Jurczak J., and Gołe{ogonek}biowski A. Chem. Rev. 89 (1989) 149-164
131. Reetz M.T., Drenes M.W., and Schmitz A. Angew. Chem., Int. Ed. Engl. 26 (1987) 1141-1143
132. Clayden J., Collington E.W., and Warren S. Tetrahedron Lett. 34 (1993) 1327-1330
133. Clayden J., McElroy A.B., and Warren S. J. Chem. Soc., Perkin Trans. 1 (1995) 1913-1934
134. Krawiecka B., and Jerziorna A. Tetrahedron Lett. 46 (2005) 4381-4384
135. Mlynarski J., and Paradowska J. Chem. Soc. Rev. 37 (2008) 1502-1511
136. Saito S., and Yamamoto H. Acc. Chem. Res. 37 (2004) 570-579
137. Mahrwald R. Modern Aldol Reactions (2004), Wiley-VCH, Weinheim, Germany
138. Denmark S.E., and Stavenger R.A. Acc. Chem. Res. 33 (2000) 432-440
139. Mahrwald R. Chem. Rev. 99 (1999) 1095-1120
140. Heathcock C.H. Asymmetric Synthesis Vol. 3 (1984), Academic Press, New York 111-212
141. Franklin A.S., and Paterson I. Contemp. Org. Synth. 1 (1984) 317-318
142. Mukaiyama T. Org. React. 28 (1982) 203-331
143. Evans D.A., Nelson J.V., and Taber T.R. Top. Stereochem. 13 (1982) 1-115
144. For the synthesis and reactions of α-N-Boc-aminoaldehydes, see:. Hu B., Xiao K., and Shen J.K. Chin. Chem. Lett. 17 (2006) 1162-1164
145. Prasad J.V.N.V., Loo J.A., Boyer F.E., Stier M.A., Gogliotti R.D., Turner W.J., Harvey P.J., Kramer M.R., Mack D.P., Scholten J.D., Gracheck S.J., and Domagala J.M. Bioorg. Med. Chem. 6 (1998) 1707-1730
146. Smrcina M., Majer P., Majerová E., Guerassina T.A., and Eissenstat M. Tetrahedron 53 (1997) 12867-12874
147. Veeresh G., and Datta A. Tetrahedron Lett. 38 (1997) 5223-5224
148. Dinh T.Q., and Armstrong R.W. J. Org. Chem. 61 (1996) 6606-6616
149. Zlatodsky P. Tetrahedron Lett. 36 (1995) 7281-7284
150. Dias L.C., Fattori J., and Perez C.C. Tetrahedron Lett. 49 (2008) 557-561
151. Dinh T.Q., and Armstrong R.W. J. Org. Chem. 60 (1995) 8118-8119
152. Dellaria Jr. J.F., and Maki R.G. Tetrahedron Lett. 27 (1986) 2337-2340
153. Shalem H., Shatzmiller S., and Feit B.-A. Liebigs Ann. (1995) 433-436
154. Garner P., and Park J.M. In: Meyers A.I. (Ed). Organic Synthesis. Vol. 70 (1992), John Wiley & Sons, New York 18
155. Martin S.F., Dean D.W., and Wagman A.S. Tetrahedron Lett. 33 (1992) 1839-1842
156. Obayashi M., Eiji I., Matsui K., and Kondo K. Tetrahedron Lett. 23 (1982) 2323-2326
157. Otaka A., Miyoshi K., Burke Jr. T.R., Roller P.P., Kubota H., Tamamura H., and Fujii N. Tetrahedron Lett. 36 (1995) 927-930
158. For the reaction of the lithium salt of diethyl (difluoromethyl)phosphonate with racemic aldehydes, see:. Adams L.A., Charmant J.P.H., Cox R.J., Walter M., and Whittingham W.G. Org. Biomol. Chem. 2 (2004) 542-553
159. For the synthesis of 120, see:. Berkowitz D.B., Shen Q., and Maeng J.-H. Tetrahedron Lett. 35 (1994) 6445-6448
160. Yokomatsu T., Takechi H., Akiyama T., Shibuya S., Kominato T., Soeda S., and Shimeno H. Bioorg. Med. Chem. Lett. 11 (2001) 1277-1280
161. Yokomatsu T., Murano T., Akiyama T., Koizumi J., Shibuya S., Tsuji Y., Soeda S., and Shimeno H. Bioorg. Med. Chem. Lett. 13 (2003) 229-236
162. Kolter T., and Sandhoff K. Angew. Chem., Int. Ed. 38 (1999) 1532-1568
163. Levade T., and Jaffrézou J.-P. Biochim. Biophys. Acta 1438 (1999) 1-17
164. Chatterjee S. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1523-1533
165. O'Brien P., and Warren S. Tetrahedron Lett. 37 (1996) 4271-4274
166. O'Brien P., Powell H.R., Raithby P.R., and Warren S. J. Chem. Soc., Perkin Trans. 1 (1997) 1031-1039
167. Lin G.-Q., Li Y.-M., and Chan A.S.C. Principles and Applications of Asymmetric Synthesis (2001), John Wiley & Sons, New York
168. Bolm C., Hildebrand J.P., and Muñiz K. In: Ojima I. (Ed). Catalytic Asymmetric Synthesis (2000), John Wiley & Sons, New York Cap. 6E
169. Li G., Chang H.-T., and Sharpless K.B. Angew. Chem., Int. Ed. 35 (1996) 451-454
170. Bodkin J.A., and McLeod M.D. J. Chem. Soc., Perkin Trans. 1 (2002) 2733-2746
171. Muñiz K. Chem. Soc. Rev. 33 (2004) 166-174
172. Thomas A.A., and Sharpless K.B. J. Org. Chem. 64 (1999) 8379-8385
173. Hentges S.G., and Sharpless K.B. J. Am. Chem. Soc. 102 (1980) 4263-4265
174. Jacobsen E.N., Marko I., Mungall W.S., Schroeder G., and Sharpless K.B. J. Am. Chem. Soc. 110 (1988) 1968-1970
175. Lohray B.B. Tetrahedron: Asymmetry 3 (1992) 1317-1349
176. ohnson R.A., and Sharpless K.B. In: Ojima I. (Ed). Catalytic Asymmetric Synthesis (2000), John Wiley & Sons, New York 357-398
177. Kolb H.C., VanNieuwenhze M.S., and Sharpless K.B. Chem. Rev. 94 (1994) 2483-2547
178. Cha J.K., and Kim N.-S. Chem. Rev. 95 (1995) 1761-1795
179. For the catalytic asymmetric dihydroxylation of β,γ-unsaturated phosphonates, see:. Yokomatsu T., Yamagishi T., Suemune K., Yoshida Y., and Shibuya S. Tetrahedron 54 (1998) 767-780
180. Yokomatsu T., Yamagishi T., Sada T., Suemune K., and Shibuya S. Tetrahedron 54 (1998) 781-790
181. Gololobov Y.G., and Kasukhin L.F. Tetrahedron 48 (1992) 1353-1406 and references cited therein
182. Tian W.Q., and Wang Y.A. J. Org. Chem. 69 (2004) 4299-4308
183. Chen S., and Yuan C. Phosphorous, Sulfur Silicon 82 (1993) 73-78
184. For the synthesis of β-ketophosphonates derived from serine and their aplication in the Horner-Wadsworth-Emmons reaction, see:. Lee J.-M., Lim H.-S., and Chung S.-K. Tetrahedron: Asymmetry 13 (2002) 343-347
185. Chung S.-K., and Lee J.-M. Tetrahedron: Asymmetry 10 (1999) 1441-1444
186. Koskinen A.M.P., and Koskinen P.M. Synlett (1993) 501-502
187. Koskinen A.M.P., and Koskinen P.M. Tetrahedron Lett. 34 (1993) 6765-6768
188. Koskinen A.M.P., and Krische M.J. Synlett (1990) 665-666
189. Heathcock C.H., and Von Gelden T.W. Heterocycles 25 (1987) 75-78
190. The diastereoisomeric ratio was not reported.
191. Berkowitz D.B., Eggen M.-J., Shen Q., and Shoemaker R.K. J. Org. Chem. 61 (1996) 4666-4675
192. For the diastereoselective reduction of β-ketophosphonates, see:. Rojas-Cabrera H., Ochoa-Morales J., Hernández-Núñez E., Fernández-Zertuche M., and Ordóñez M. J. Mex. Chem. Soc. 51 (2007) 237-244
193. Rojas-Cabrera H., Hernández-Pérez J.M., Hô M., Hernández-Fernández E., and Ordóñez M. Tetrahedron: Asymmetry 19 (2008) 161-166
194. For the synthesis of β-ketophosphonates derived from α-amino acids and their aplication in the Horner-Wadsworth-Emmons reaction, see:. Captain L.F., Xia X., and Liotta D.C. Tetrahedron Lett. 37 (1996) 4293-4296
195. Déziel R., Plante R., Caron V., Grenier L., Llinas-Brunet M., Duceppe J.-S., Malenfant E., and Moss N. J. Org. Chem. 61 (1996) 2901-2903
196. Lucet D., Le Gall T., Mioskowski C., Ploux O., and Marquet A. Tetrahedron: Asymmetry 7 (1996) 985-988
197. Chung S.-K., and Kang D.-H. Tetrahedron: Asymmetry 8 (1997) 3027-3030
198. Våbenø J., Brisander M., Lejon T., and Luthman K. J. Org. Chem. 67 (2002) 9186-9191
199. Shikata K., Azuma H., Tachibana T., and Ogino K. Tetrahedron 58 (2002) 5803-5809
200. Rodriguez A.C., Ramos A.P., Hawkes G.E., Berti F., and Resmini M. Tetrahedron: Asymmetry 15 (2004) 1847-1855
201. Våbenø J., Nielsen C.U., Ingebrigtsen T., Lejon T., Steffansen B., and Luthman K. J. Med. Chem. 47 (2004) 4755-4765
202. Tao J., Hu S., Tian Q., Nayyar N., and Babu S. Tetrahedron: Asymmetry 16 (2005) 699-703
203. Lee H.K., Im J.H., and Jung S.H. Tetrahedron 63 (2007) 3321-3327
204. Ordóñez M., De la Cruz-Cordero R., Fernández-Zertuche M., and Muñoz-Hernández M.A. Tetrahedron: Asymmetry 13 (2002) 559-562
205. Cherest M., and Felkin H. Tetrahedron Lett. 9 (1968) 2199-2204
206. Cherest M., and Felkin H. Tetrahedron Lett. 9 (1968) 2205-2208
207. Anh N.T., and Eisenstein O. Nouv. J. Chem. 1 (1977) 61-70
208. For an excellent summary, see:. Eliel E.L., Wilen S.H., and Mander L.N. Stereochemistry of Organic Compounds (1994), John Wiley & Sons, New York
209. For the synthesis of β-ketophosphonates derived from l-proline and derivatives, see:. Verbicky C.A., and Zercher C.K. J. Org. Chem. 65 (2000) 5615-5622
210. Hanessian S., Claridge S., and Johnstone S. J. Org. Chem. 67 (2002) 4261-4272
211. Ordóñez, M.; Lagunas-Rivera, S.; Hernández-Núñez, E.; Labastida-Galván, V. Master's Thesis, UAEM 2005, submitted for publication.
212. Ordóñez M., De la Cruz-Cordero R., Fernández-Zertuche M., Muñoz-Hernández M.A., and García-Barradas O. Tetrahedron: Asymmetry 15 (2004) 3035-3043
213. Ordóñez M., De la Cruz-Cordero R., Quiñónes C., and González-Morales A. Chem. Commun. (2004) 672-673
214. De la Cruz-Cordero R., Hernández-Núñez E., Fernández-Zertuche M., Muñoz-Hernández M.A., and Ordóñez M. ARKIVOC vi (2005) 277-286
215. De la Cruz-Cordero R., Labastida-Galván V., Fernández-Zertuche M., and Ordóñez M. J. Mex. Chem. Soc. 49 (2005) 312-321
216. Cui P., Tomsig J.L., McCalmont W.F., Lee S., Becker C.J., Lynch K.R., and Macdonald T.L. Bioorg. Med. Chem. Lett. 17 (2007) 1634-1640
217. The authors did not report the diastereoselective ratio.
218. Cui P., McCalmont W.F., Tomsig J.L., Lynch K.R., and Macdonald T.L. Bioorg. Med. Chem. 16 (2008) 2212-2225
219. Głowacka I.E. Tetrahedron: Asymmetry 20 (2009) 2270-2278